Cargando…
Clinical application of vancomycin population pharmacokinetics model in patients with hematological diseases and neutropenia
To explore the clinical application of a population pharmacokinetics (PPK) model of vancomycin in patients with hematological diseases and neutropenia. Patients with hematological diseases and neutropenia were included in the PPK model study. Nonlinear mixed effect modeling approach (NONMEM) was use...
Autores principales: | Fu, Xiangjun, Lin, Liangmo, Huang, Li, Guo, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297986/ https://www.ncbi.nlm.nih.gov/pubmed/34651308 http://dx.doi.org/10.1002/bdd.2303 |
Ejemplares similares
-
Altered Pharmacokinetics Parameters of Vancomycin in Patients with Hematological Malignancy with Febrile Neutropenia, a Bayesian Software Estimation
por: Alzahrani, Abdullah M., et al.
Publicado: (2023) -
A Systematic Review of Vancomycin Dosing in Patients with Hematologic Malignancies or Neutropenia
por: He, Na, et al.
Publicado: (2020) -
394 Influence of febrile neutropenia on the pharmacokinetics and dosage requirements of vancomycin
por: Shiotsuka, Shouichi, et al.
Publicado: (2014) -
Population pharmacokinetic modeling and clinical application of vancomycin in Chinese patients hospitalized in intensive care units
por: Lin, Zhong, et al.
Publicado: (2021) -
External Evaluation of Vancomycin Population Pharmacokinetic Models at Two Clinical Centers
por: Liu, Yi-Xi, et al.
Publicado: (2021)